155 publications
Name | Date | Type | Actions |
---|---|---|---|
2023 HALF-YEAR RESULTS Sales: €256m (-5.4% as reported) |
07/09/2023 | Public releases | |
2023 Half-Year Results Contents |
07/09/2023 | Half Year Report | |
Buyback programs - July Monthly communication regarding buyback programs |
22/08/2023 | Description of buyback programs | |
Monthly information regarding the total number of voting rights - July 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
22/08/2023 | Voting rights | |
Mastaplex and Vetoquinol announce distribution agreement Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest.. |
27/07/2023 | Press releases communication | |
Update July 11, 2023 2023 CALENDAR OF FINANCIAL COMMUNICATION Update July 11, 2023 |
12/07/2023 | Agenda | |
Rapport financier semestriel 2022 (french) Rapport financier semestriel 2022 (french) |
26/06/2023 | Half Year Report | |
Growth driven by innovation Ever since the company was founded in 1933, innovation has been a major component of Vetoquinol's development strategy. |
13/06/2023 | Press releases communication | |
Rémunération et politique des dirigeants - mai 2023 (french) Rémunération et politique des dirigeants |
07/06/2023 | Shareholders´s Meeting | |
Vetoquinol - assemblée générale mixte - 25 mai 2023 : résultat du scrutin |
26/05/2023 | Shareholders´s Meeting |